Avi has spent over 20 years in the investment banking sector with 10 years of that spent with Bank Mizrahi (Israel).

Avi served as President and Chief Executive Officer of Yissum Research Development Company of the Hebrew University of Jerusalem, Israel.

Avi founded BioCancell Therapeutics a company he led from a mere concept through clinical trials to a successful IPO.  Avi was also a Member of Board of Directors at Gefen Biomed Investments.

Specialties: Venture Capital, Business Strategy, Strategic Partnerships